IL-4 Expression at the Onset of Islet Inflammation Predicts Nondestructive Insulitis in Nonobese Diabetic Mice

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2414-2424

  Fox, Casey J ^b   Danska, Jayne S ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOLOGY; SECRETION; SEX DIFFERENCE; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MOVEMENT; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; SEX FACTORS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0031092631     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Castano, L., and G. S. Eisenbarth. 1990. Type-1 diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647.
2. Rossini, A. A., D. L. Greiner, H. P. Friedman, and J. P. Mordes. 1993. Immunopathogenesis of diabetes mellitus. Diabetes Metab. Rev. 1:43.
3. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29:1.
4. Acha-Orbea, H., and H. O. McDevitt. 1987. The first external domain of the non-obese diabetic mouse class II I-Aβ chain is unique. Proc. Natl. Acad. Sci. USA 84:2435.
5. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
6. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. M. Bridgett, and E. H. Leiter. 1994. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180:1553.
7. Miller, B. J., M. C. Appel, J. J. O'Neil, and L. S. Wicker. 1988. Both the Lyt-2 and L3T4 T cell subsets are required for the transfer of diabetes in non-obese diabetic mice. J. Immunol. 140:52.
8. Christianson, S. W., L. D. Shultz, and E. H. Leiter. 1993. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Diabetes 42:44.
9. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 88:527.
10. Lee, K. U., K. Amano, and J. Y. Yoon. 1988. Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 37:989.
11. Hutchings, P., H. Rosen, O. O'Reilly, E. Simpson, S. Gordon, and A. Cooke. 1990. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348:639.
12. Jansen, A., F. Homo-Delarche, H. Hooijkaas, P. J. Leenen, M. Dardenne, and H. A. Drexhage. 1994. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of insulitis and β-cell destruction in NOD mice. Diabetes 43:667.
13. Jarpe, A. M., J. Hickman, J. Anderson, W. Winter, and A. Peck. 1991. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes. Reg. Immunol. 3:305.
14. Signore, A., P. Pozzilli, E. A. M. Gale, D. Andreani, and P. C. L. Beverley. 1989. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetes 32:282.
15. Rabinovitch, A., W. L. Suarez-Pinzon, O. Sorenson, R. C. Bleackley, and R. F. Power. 1995. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in non-obese diabetic mice. J. Immunol. 154:4874.
16. Waters, S. H., J. J. O'Neill, D. T. Melican, and M. C. Appel. 1992. Multiple TCR Vβ usage by infiltrates of young NOD mouse islets of Langerhans. Diabetes 41:308.
17. Pozzilli, P., A. Signore, A. J. K. Williams, and P. E. Beales. 1993. NOD colonies around the world: recent facts and figures. Immunol. Today 14:193.
18. + T cell clones: differential requirement for CD8 cells. Diabetes 45:328.
19. Marrack, P., R. Endres, R. Shimonkevitz, A. Zlotnik, D. Dialynas, F. W. Fitch, and J. Kappler. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 products. J. Exp. Med. 158:1077.
20. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
21. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4. and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
22. Prabhu Das, M. R., S. S. Zamvil, F. Borriello, H. L. Weiner, A. H. Sharpe, and V. K. Kuchroo. 1995. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25:207.
23. Lenschow, D. L., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14:233.
24. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. W. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
25. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 9:271.
26. H2 and more. Immunol. Today 17:138.
27. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Berenstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
28. H2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
29. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the non-obese diabetic mouse. J. Exp. Med. 181:1145.
30. Wong, S., S. Guerder, I. Visintin, E.-P. Reich, K. E. Swenson, R. A. Flavell, and C. A. Janeway. 1995. Expression of the co-stimulator molecule B7-1 in pancreatic β-cells accelerates diabetes in the NOD mouse. Diabetes 44:326.
31. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin-12 administration induces T helper type I cells and acclerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
32. Rapoport, M., A. Jaramillo, D. Zipris, A. H. Lazarus, D. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in non-obese diabetic mice. J. Exp. Med. 178:87.
33. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in non-obese diabetic mice. J. Exp. Med. 184:1093.
34. Serreze, D. V., K. Hamaguchi, and E. H. Leiter. 1989. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.
35. Satoh, J., H. Seino, T. Abo, S.-I. Tanaka, S. Shintani, S. Ohta, K. Tamura, T. Sawai, T. Nobunaga, T. Oteki, K. Kumagai, and T. Toyota. 1989. Recombinant human tumour necrosis factor-α suppresses autoimmune diabetes in non-obese diabetic mice. J. Clin. Invest. 84:1345.
36. Yang, X.-D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber, and H. O. McDevitt. 1994. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995.
37. Campbell, I. L., T. W. H. Kay, L. Oxbrow, and L. C. Harrison. 1991. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:389.
38. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa, and J.-F. Bach. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFNγ. J. Autoimmun. 4:237.
39. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in non-obese diabetic mice by tumor necrosis factor (TNF): similarities between TNFα and interleukin 1. Proc. Natl. Acad. Sci. USA 87:968.
40. Lee, M.-S., R. Mueller, L. S. Wicker, L. B. Peterson, and N. Sarvetnick. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663.
41. Pennline, K. J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the non-obese diabetic mouse. Clin. Immunol. Immunopathol. 71:169.
42. Wogenson, L., M.-S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in non-obese diabetic mice. J. Exp. Med. 179:1379.
43. Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. Miyazaki, S. Ii, E. Kudo, H. Iwahana, Y. Hayashi, and T. Sano. 1994. Transgenic expression of IL-10 in pancreatic islet a cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927.
44. + cytotoxic T-cells response in autoimmune diabetes-prone NOD mice. Diabetes 45:902.
45. Serreze, D. V., and E. H. Leiter. 1995. Insulin dependent diabetes mellitus (IDDM) in NOD mice and BB rats: origins in hematopoetic stem cell defects and implications for therapy. In Lessons from Animal Diabetes V. E. Shafrir, ed. Smith-Gordon, London, p. 59.
46. Baxter, A., M. Koulamanda, and T. Mandel. 1991. High and low diabetes incidence non-obese diabetic (NOD) mice: origins and characterization. Autoimmunity 9:61.
47. Wilberz, S., H. J. Partke, F. Dagnaes-Hansen, and L. Herberg. 1991. Persistent MHV (mouse hepatis virus) infection reduces the incidence of diabetes mellitus in the non-obese diabetic mouse. Diabetologia 34:2.
48. Galley, K. A., and J. S. Danska. 1995 Peri-islet infiltrates of young non-obese diabetic mice display restricted TCR β-chain diversity. J. Immunol. 154:2969.
49. Danska, J. S., A. M. Livingstone, V. Paragas, and C. G. Fathman. 1990. The presumptive CDR3 of both T cell receptor α and β chains mediate recognition of myoglobin peptides. J. Exp. Med. 172:27.
50. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
51. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5 using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
52. Gold, D. P., H. Clevers, B. Alarcon, S. Dunlap, J. Novotny, A. Williams, and C. Terhorst. 1987. Evolutionary relationship between the T3 chains of the T-cell receptor complex and the immunoglobulin superfamily. Proc. Natl. Acad. Sci. USA 84:7649.
53. Freeman, G. J., G. S. Gray, C. D. Gimmi, D. B. Lombard, L.-J. Zhou, M. White, J. P. Fingeroth, J. G. Gribber, and L. M. Nadler. 1991. Structure, expression and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174:625.
54. Estess, P., A. B. Begovich, M. Koo, P. P. Jones, and H. O. McDevitt. 1986. Sequence analysis and structure-function correlations of murine q, k, u, s, and f haplotype I-Aβ cDNA clones. Proc. Natl. Acad. Sci. USA 83:3594.
55. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
56. Hu-Li, J., J. Ohara, C. Watson, W. Tsang, and W. E. Paul. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800.
57. Karasuyama, H., A. Rolink, Y. Shinkai, F. Young, F. W. Alt, and F. Melchers. 1994. The expression of Vpre-B/15 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell 77:133.
58. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Leiter. 1992. The NOD-scid mouse: a model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89:3290.
59. Shackelford, D. A., A. V. Smith, and I. S. Trowbridge. 1987. Changes in cytokine gene expression are induced by a phorbol diester: expression of IL-2 receptor, T3, and T cell antigen receptor. J. Immunol. 138:613.
60. Winoto, A., and D. Ballimore. 1989. A novel, inducible and T cell-specific enhancer located at the 3′ end of the T cell receptor a locus. EMBO J. 8:729.
61. Brorson, K. A., B. Berverly, S.-M. Kange, M. Lenardo, and R. H. Schwartz. 1991. Transcriptional regulation of cytokine genes in nontransformed T cells. J. Immunol. 147:3601.
62. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in non-obese diabetic mice. J. Exp. Med. 182:87.
63. Bergman, B., and K. Haskins. 1994. Islet-specific T cell clones from the NOD mouse respond to β-granule antigen. Diabetes 43:197.
64. Haskins, K., M. Portas, K. Bergman, K. Lafferty, and B. Bradley. 1989. Pancreatic islet specific T cell clones from non-obese diabetic mice. Proc. Natl. Acad. Sci. USA 86:8000.
65. H2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95:2979.
66. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
67. 1 mice. J. Immunol. 153: 2800.
68. Wegmann, D. R., R. G. Gill, M. Norbury-Glaser, N. Schloot, and D. Daniel. 1994. Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmun. 7:833.
69. Sarvetnick, N., J. Shiruzu, D. Liggitt, L. Martin, B. McIntyre, A. Gregory, T. Parslow, and T. Stewart. 1990. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 346:844.
70. Shehadeh, N., F. LaRosa, and K. J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291.
71. Rabinovitch, A., O. Sorenson, W. L. Suarez-Pinton, R. F. Power, R. V. Rajotte, and R. C. Bleackley. 1994. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon γ mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 37:833.
72. Edouard, P., C. Thivolet, P. Bedossa, M. Olivi, B. Legrand, A. Bendelac, J. Bach, and C. Carnaud. 1993. Evidence for a preferential Vβ usage by the T cells which adoptively transfer diabetes in NOD mice. Eur. J. Immunol. 23:727.
73. Maeda, T., T. Sumida, K. Kurasawa, H. Tomioka, I. Itoh, S. Yoshida, and T. Koike. 1991. T lymphocyte-receptor repertoire of infiltrating T lymphocytes into NOD mouse pancreas. Diabetes 40:1580.
74. Yang, Y., B. Charlton, A. Shimada, R. Dal Canto, and C. G. Fathman. 1996. Monoclonal T cells identified in early NOD islet infiltrates. Immunity 4:189.
75. Candeidas, S., J. Katz, C. Benoist, D. Mathis, and K. Haskins. 1991. Islet-specific T-cell clones from non-obese diabetic mice express heterogeneous T-cell receptors. Proc. Natl. Acad. Sci. USA 88:6167.
76. Nakano, N., H. Kikutani, H. Nishimoto, and T. Kishimoto. 1991. T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice. J. Exp. Med. 171:1091.
77. Kaufman, D. L., M. Clare-Salzer, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
78. Tisch, R., X. Yang, S. M. Singer, R. S. Liblau, L. Fugger, and H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72.
79. Campbell, I. L., A. Iscaro, and L. C. Harrison. 1988. IFN-γ and tumor necrosis factor-α: cytotoxicity to murine islets of Langerhans. J. Immunol. 141:2325.
80. Pukel, C., H. Baquerizo, and A. Rabinovitch. 1988. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37:133.
81. Shimada, A., B. Charlton, C. Taylor-Edwards, and C. G. Fathman. 1996. β cell destruction may be a late consequence of the autoimmune process in non-obese diabetic mice. Diabetes 45:1063.
82. Signore, A., E. Procaccini, A. M. Toscano, E. Ferretti, A. J. K. Williams, P. E. Beales, P. Cugini, and P. Pozzilli. 1994. Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry 101:263.
83. Ahmed, S. A., W. J. Penhale, and N. Talal. 1985. Sex hormones, immune responses and autoimmune diseases. Am. J. Pathol. 121:531.
84. Owerbach, D., and K. H. Gabbay. 1996. The search for IDDM susceptibility genes: the next generation. Diabetes 45:544.